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Mutations in the guanine nucleotide binding -subunit 1 gene
(GNAS1) cause Albright’s hereditary osteodistrophy, and the
parent of transmission determines variable phenotypic ex-
pression of the disease. This has suggested that GNAS1 may be
under tissue-specific imprinting control, although studies so
far available have failed to clearly define the pattern of GNAS1
expression in humans. To establish if GNAS1 is imprinted in
human endocrine tissues, we selected 14 thyroid, 10 granulosa
cell, 13 pituitary (3 normal glands, 7 GH-secreting adenomas,
and 3 nonfunctioning adenomas), 3 adrenal, and 11 lympho-
cyte samples shown to be heterozygous for a known polymor-
phism in exon 5. RNA from these tissues was analyzed by
RT-PCR, and expression from both parental alleles was eval-
uated by enzymatic digestion and subsequent quantification
of the resulting fragments. The parental origin of Gs was
assessed by evaluating neuroendocrine secretory protein 55
and extra large s-like protein transcripts, which have been
shown to be monoallelically and parent-specifically expressed
from the maternal and paternal allele, respectively. By this
approach, the great majority of thyroid (n  12), ovarian (n 
7), and pituitary (n 11) samples showed an almost exclusive
or significantly predominant expression of the maternal allele
over the paternal one, whereas in lymphocyte and adrenal
samples both alleles were equally expressed. Our results pro-
vide evidence for a predominant maternal origin of GNAS1
transcripts in different human adult endocrine tissues, par-
ticularly thyroid, ovary, and pituitary, and strongly suggest
that this mechanism may play a crucial role in the determi-
nation of the phenotypic expression of Albright’s hereditary
osteodistrophy. (J Clin Endocrinol Metab 87: 4736–4740, 2002)
GENOMIC IMPRINTING IS an epigenetic phenomenonaffecting a small number of genes by which one allele
(maternal or paternal) undergoes, either during the embry-
ogenesis or in the postnatal period, a partial or total loss of
expression (1). In humans, imprinting plays a role in the
pathogenesis of various disorders, such as Angelman, Beck-
with-Wiedeman, and Prader-Willi syndromes. More re-
cently, Liu et al. (2) identified in patients affected with
pseudohypoparathyroidism (PHP) type Ib (3) an imprinting
defect of guanine nucleotide binding -subunit 1 gene
(GNAS1), which is likely to be involved in the pathogenesis
of the disease.
GNAS1 maps on human chromosome 20q13 and on mouse
distal chromosome 2. Both regions have been recently shown
to be under complex imprinting control (4–8). In fact, by
using alternative promoters and first exons splicing into a
common site in exon 2, the GNAS1 locus gives rise not only
to the Gs gene, but to at least three other gene products, i.e.
the extra large s-like protein (XLs) (9), the neuroendocrine
secretory protein 55 (NESP55) (10) and a nontranslated tran-
script deriving from Exon 1A (11) (Fig. 1). A fourth antisense
transcript is believed to play a role in regulating NESP55
expression (12). The XLs, antisense, and 1A transcripts are
expressed only from the paternal allele, whereas NESP55 is
expressed specifically from the maternal allele.
Heterozygous loss of function mutations in GNAS1 in-
herited from the mother lead to PHP type Ia, in which Al-
bright’s hereditary osteodistrophy (AHO), a disorder char-
acterized by a constellation of physical features, is associated
to end organ resistance to the action of different hormones,
primarily PTH, TSH, and gonadotropins. Interestingly, when
the same mutations are inherited from the father, patients
show the physical abnormalities of AHO, without any evi-
dence of hormone resistance (pseudo-pseudohypoparathy-
roidism, PPHP) (13, 14).
Although the pattern of inheritance of PHP Ia is consistent
with imprinting of GNAS1 paternal allele, different expres-
sion studies on RNA from various human fetal tissues have
failed to demonstrate monoallelic expression of this gene (15,
16). Consistent with the view that genomic imprinting may
be a phenomenon restricted to selective tissues and evolving
in postnatal life, monoallelic expression of the Gs gene has
been recently shown in the human adult pituitary, although
this gland is not classically included among the target organs
resistant to hormone action in AHO (17–19). The aim of this
study was to investigate Gs allelic expression and parental
origin in human adult endocrine tissues that are differen-
tially involved in the determination of PHP Ia phenotype.
Materials and Methods
Tissues
The study included 25 normal perinodular thyroid tissues obtained
from patients undergoing surgery for multinodular goiter or toxic ad-
enoma; 22 granulosa cell specimens (from ovarian follicular fluid) from
patients undergoing in vitro fertilization because of idiopathic infertility;
27 pituitary tissues, including 6 normal glands obtained at autopsy, 13
GH-secreting and 7 nonfunctioning pituitary adenomas surgically re-
moved from patients with pituitary adenomas; 6 normal perinodular
Abbreviations: AHO, Albright’s hereditary osteodistrophy; GNAS1,
guanine nucleotide binding -subunit 1 gene; NESP55, neuroendocrine
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adrenal glands obtained from patients undergoing surgery for benign
cortical adenomas, and 20 blood samples from normal subjects.
Informed consent was obtained in all cases, and prior project ap-
proval was given by the local ethic committee.
PCR, RT-PCR, and digestions
DNA and RNA were extracted from all samples with standard meth-
ods. Exon 5 (GenBank accession no. M21741 J03647) was amplified from
genomic DNA by PCR using the primers and under the conditions
described previously (sense: 5-ATGAAAGCAGTACTCCTAACTGA-
3; antisense: 5-TGGATGCTCCTGCCCATGTG-3) (20). The amplified
products were then screened by digestion for a silent T to C polymor-
phism (Ile 131, nucleotides 297–299) that creates an FokI site (1 h at 37
C, with 1 U of enzyme). Heterozygosity for this polymorphism was then
confirmed by direct sequencing (ABI-PRISM 310, PE Applied Biosys-
tems, Foster City, CA).
To examine allele-specific gene expression, 5 g total RNA were
reverse transcribed (Promega Corp., Madison WI) and then subjected to
PCR (28 cycles at 94/58/72 C for 45/45/45 sec) using a common down-
stream primer (5-CCTTGGCATGCTCATAGAATTC-3) (5) located in
exon 6 and 3 exon 1-specific upstream primers amplifying Gs (GenBank
accession no. M21139 J03647, nucleotides 789–807), XLs (GenBank
accession no. AJ 251760, nucleotides 16000–16021), and NESP55 (Gen-
Bank accession no. AJ 251760, nucleotides 1432–1451) genes, respectively
(Gs: 5-CCATGGGCTGCCTCGGGAACA-3; XLs:5-CGCAGTA-
AGCTCATCGACAAAG-3; NESP55: 5-AGCCCGAGGACAAAGA-
TCCA-3). RT-PCR products were digested with FokI as for genomic
DNA and visualized on 2% Nusieve-1% agarose gels. Bands from Gs
RT-PCR were finally evaluated by an imaging densitometer (GS-700,
Bio-Rad Laboratories, Inc., Richmond, CA), and the maternal contribu-
tion was calculated as a percentage of the sum of the normalized values
for the two alleles.
Somatotroph adenomas were also screened for somatic mutations at
codon 201 or 227 of the Gs gene (the gsp oncogene) as previously
described (21).
Results
The evaluation of parental origin of transcription of the
Gs gene was carried out on samples found to be heterozy-
gous for the polymorphism in exon 5, that is 14 thyroid, 10
granulosa cell, 13 pituitary (3 normal glands, 7 GH-secreting
adenomas, 3 of which were gsp, and 3 nonfunctioning
adenomas), 3 adrenal, and 11 lymphocyte samples. The pa-
rental origin of Gs transcripts was established by FokI di-
gestion and direct sequencing of NESP55 and XLs tran-
scripts. Both analyses showed the expected monoallelic
expression from opposite alleles. In particular, when a NESP-
derived transcript showed to carry the polymorphism, i.e. the
correspondent band was digested by Fok1, the Xls-derived
transcript from the same sample always displayed a wild-
type sequence and was not digested by the same enzyme. In
contrast, Gs-derived transcripts were always biallelically
expressed but, with the exception of two samples, all thyroid
tissues showed a significant predominant expression of the
maternal allele over the paternal one (Figs. 2A and 4), i.e. the
most expressed allele was always the same represented in
NESP55 transcripts (ratio maternal/total 100  sd: 75.7 
13.4%). In particular, in five samples we observed a striking
predominance of the maternally derived transcript (89.6 
4.4%), whereas in the other seven this phenomenon was seen
at a lesser but still significant extent (72.7 4.3%). Moreover,
in two patients we could compare Gs allelic expression
between thyroid gland and lymphocytes from peripheral
blood. As shown in Fig. 2B, the predominance of the maternal
allele observed in the thyroid was absent in lymphocyte
samples.
Seven of 10 granulosa cell samples showed a less striking
but still significant predominance of the maternal allele
(68.8  6.7%) (Figs. 3 and 4).
A striking predominance of the maternal allele was ob-
served in both normal and adenomatous pituitary tissues. In
particular, all the normal pituitaries (n  3) displayed an
almost exclusive Gs expression from the maternal allele
(92.3  3%), with a maximum 11% contribution from the
paternal one. With the exception of two adenomas (one gsp-
GH-secreting and one nonfunctioning tumor) in which the
two alleles were equally expressed, a similar pattern of ex-
pression was demonstrated in the adenomatous samples
(87.8  7.8%), with no difference observed between non-
functioning and GH-secreting adenomas (either gsp or
gsp) (Figs. 2C and 4).
In all adrenal and lymphocyte samples, both the paternal
and the maternal alleles were expressed at the same extent
(Fig. 4).
Discussion
Our study first demonstrates that, in specific endocrine
tissues, GNAS1 transcription mainly derives from the ma-
ternal allele. In particular, a predominant, though not ex-
clusive, maternal origin of Gswas observed in adult human
thyroid, ovarian cells and pituitary, whereas in the adrenal
both the paternal and maternal alleles were equally ex-
pressed. The cell specificity of GNAS1 imprinting was
strongly supported by the experiments showing a similar
maternal and paternal contribution to GNAS1 expression in
lymphocytes obtained from subjects in whom the removed
thyroid only expressed the maternally derived GNAS1. In
tissues mainly expressing the maternal allele, the predomi-
nance of the maternally derived transcript occurred at a
variable extent in different samples, being almost exclusive
in the majority of pituitary samples, largely predominant in
most thyroid samples and less striking, but still significantly
FIG. 1. Genomic organization of human GNAS locus. The figure
shows four alternative first exons that splice into exon 2, generating
four different transcripts: Gs, NESP55, XLs, and a noncoding gene
product from exon 1A. Both the maternal and paternal alleles are
shown: arrows designate transcription start sites. An additional an-
tisense transcript has been recently demonstrated to be expressed
only from the paternal allele. The arrowhead marks the polymorphic
FokI site in exon 5; gray arrows indicate RT-PCR primers.
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higher than the paternally derived transcript, in granulosa
cells. This variable pattern of GNAS1 imprinting is consistent
with the incomplete transcriptional repression of other im-
printed genes that have been previously observed in indi-
vidual tissues (22–24), indicating that imprinting is not
necessarily an all-or-nothing phenomenon. Mechanisms un-
derlying these findings include either biallelic expression by
a subset of cells within a tissue or an only partial silencing
of one allele in all cells of such tissues. Moreover, the dif-
ference observed among different samples, particularly
among granulosa cell preparations, might also be, at least
partially, attributed to the different degree of contamination
of tissue samples by the peripheral blood, which biallelically
expressed GNAS1.
The data reported here strongly support the hypothesis
that imprinting of the Gs gene is the potential mechanism
responsible for occurrence of variable resistance to hormone
action in patients with GNAS1 mutations. First, the predom-
inant, though not exclusive, maternal origin of Gs is con-
sistent with the pattern of inheritance of PHP Ia. Indeed,
FIG. 2. GNAS1 expression patterns in differ-
ent human tissue samples derived from RT-
PCR of mRNA. In each figure, arrows indicate
undigested and digested bands respectively.
Double bands observed in all samples are due
to alternative splicing of exon 3, characteristic
of all GNAS1 transcripts. A, Expression of
Gs, NESP55, and XLs genes after 1 h di-
gestion with FokI in four different thyroid (T)
samples heterozygous for the polymorphism in
exon 5. With the exception of sample T5, which
shows a comparable intensity of bands from
the two alleles, the others display a striking
predominance of one allele over the other. In
all cases, study of NESP55 and XLs expres-
sion indicated the maternal allele to be the
predominant one. Uncut (U) and cut (C) con-
trols are also shown in the figure. B, Compar-
ison of Gs expression in thyroid (T) and
lymphocytes (L) from two samples: the pre-
dominance of maternal origin of transcription
observed in thyroid samples appear to be lost
in lymphocyte ones, thus providing evidence
for tissue-specific imprinting of this gene. C,
Analysis of allelic expression of GNAS1 tran-
scripts in human pituitary glands: N, normal
pituitary; NA, nonfunctioning adenoma; gsp
and gsp, GH-secreting adenoma positive and
negative, respectively, for mutations of the gsp
oncogene.
FIG. 3. Expression of GNAS1-derived transcripts (Gs, NESP55, and
XLs) in granulosa cell extracts (G1, G2, and G3); as observed in
thyroid and pituitary samples, the maternal allele resulted to be more
expressed respect to the paternal one. However, densitometric eval-
uation of these bands demonstrated a higher contribution from the
paternal allele compared with the one seen in the pituitary and the
thyroid (see Results for more details).
FIG. 4. The diagram shows the estimated percentage of maternally
derived transcripts in 14 thyroid glands, 10 gonads (granulosa cells),
12 pituitary glands (open circles, normal ones; filled circles, soma-
totroph adenomas; filled squares, nonfunctioning adenomas), 11 lym-
phocyte samples, and 3 adrenal glands.
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mutations in GNAS1 inherited from the mother lead to PHP
type Ia, in which AHO is associated with multiple hormone
resistance, whereas the same mutations inherited from the
father lead to PPHP in which AHO is not accompanied by
any evidence of hormone resistance (13, 14). Although im-
printing of GNAS1 has been proposed to explain the occur-
rence of PHP Ia and PPHP in patients with AHO (14), ex-
pression studies carried out up to now in various human fetal
tissues have failed to demonstrate monoallelic expression of
this gene (15, 16). The recent report of GNAS1 biallelic ex-
pression in human kidney cortex (16) is only apparently in
contrast with our findings. In fact, Zheng et al. (16) carried out
their study on fetal tissues, and it has been demonstrated that
imprinting can be a process beginning and evolving in post-
natal life (25). This hypothesis is also supported by the ob-
servation that PHP Ia patients do not show any sign of
hormone resistance at birth, but they generally develop hy-
pocalcemia, hypothyroidism, and hypogonadism over child-
hood or adolescence. Moreover, the kidney cortex was stud-
ied as a whole, whereas data from mice indicate imprinting
of GNAS1 as a cell-specific phenomenon, limited to the prox-
imal renal tubule, i.e. the main PTH target tissue.
Secondly, imprinting of GNAS1 paternal allele was
present in selective tissues, such as the thyroid and the go-
nad, the two endocrine tissues that, besides the kidney, are
mostly affected in PHP Ia patients. The observation of a
different extent of maternal contribution to GNAS1 expres-
sion in thyroid and gonadal samples may explain why hy-
pothyroidism is present in the totality of patients with PHP
Ia, whereas hypogonadism is demonstrated in a lower per-
centage of cases, though it is possible that the slight differ-
ences observed in this still restricted number of samples may
not have a clinical impact. In agreement with the notion that,
with the exception of a single report (26), patients with PHP
Ia show a normal responsiveness to ACTH, both the paternal
and maternal allele was equally expressed in the adrenal
gland, thus justifying the occurrence of resistance to some
(PTH, TSH, and gonadotropins), but not all hormones that
activate Gs-coupled pathways in patients with PHP Ia.
The findings of a striking predominance of the maternal
allele in normal pituitary glands confirms the recent report
by Hayward et al. (17). These data are in contrast with what
observed in PHP Ia patients, who do not display, with the
exception of anecdotal case reports (27–29), any sign of GH
deficiency, as it would be expected by the coupling of the
GHRH receptor to the cAMP-dependent pathway via Gs
protein. However, the observation that GHRH is also effec-
tive in triggering intracellular calcium increase in soma-
totrophs could partially explain the preserved GH secretion
in these patients (30). Alternatively, it is also possible to
hypothesize a compensatory expression of the paternal allele
in the presence of a defective GNAS1 transcription, though
it remains unclear why such compensation does not occur in
the kidney, the thyroid or the gonad.
Finally, in contrast with the report by Hayward et al. (17)
of a partial loss of imprinting in somatotroph adenomas, our
data from both nonfunctioning and GH-secreting adenomas
(either carrying mutations of the gsp oncogene or not) are
similar to those observed in normal glands. Based on the
present study and given the relatively low number of cases
reported in the literature, additional studies are required to
confirm a role for GNAS1 imprinting in the pathogenesis of
acromegaly.
In conclusion, our study demonstrates a predominant ma-
ternal origin of GNAS1 transcripts in different human adult
endocrine tissues, particularly in the thyroid and the gonad.
These data strongly support the hypothesis that imprinting
of the GNAS1 gene is the potential mechanism responsible
for occurrence of variable resistance to hormone action in
patients with AHO.
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